RISK FOR HEPATIC DECOMPENSATION IN PATIENTS WITH CHRONIC HEPATITIS C
See full prescribing information for complete boxed warning.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAMES: Promacta (Novartis); Revolade (Novartis)
- INDICATIONS: Thrombocytopenic purpura, severe aplastic anemia in patients with insufficient response to immunosuppressive therapy
- CLASS: Thrombopoietin receptor (TPO) agonist
- HALF-LIFE: 21–32 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Antacids, Atorvastatin, Dairy products, Eluxadoline, Lopinavir, Mineral supplements, Olmesartan, Rosuvastatin, Selenium, Zinc
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 03/31/2024
